- ROUNDTABLE: Pharmacy’s future in sync with technology
- FDA to allow dispensing of GSK's Type 2 diabetes drug Avandia in retail pharmacies again
- Bydureon pen gets FDA approval
- Study: Participation in diabetes education associated with greater ability to self-manage
- FDA approves Bristol-Myers Squibb's, AstraZeneca's Farxiga
DEERFIELD, Ill. — Three new drugs for Type 2 diabetes made by Takeda Pharmaceutical Co. have become available in pharmacies, the company said.
The drug maker announced the availability of Nesina (alogliptin), Kazano (alogliptin; metformin hydrochloride) and Oseni (alogliptin; pioglitazone).
"Diabetes is an increasingly complex disease, and many patients require treatment to be individualized to their needs," Takeda Pharmaceuticals USA senior director for diabetes and obesity marketing Jennifer Greeby said. "The availability of Nesina, Kazano and Oseni marks an important milestone in Takeda's commitment to patients living with Type 2 diabetes and provides new options for physicians."